Tg Therapeutics, Inc.

CONGRESS ASSET MANAGEMENT CO TGTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/14/2026

Shares

2,168,081

Value ($000)

72,024

Weight

0.5%

2025 Q4 - 2026 Q1 (2 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/14/2026	72,024	0.5%	2,168,081	3/31/2026
2025 Q4	1/9/2026	57,307	0.4%	1,922,410	12/31/2025